Jubira 40 Tablet contains Rosuvastatin 40 mg, a potent lipid-lowering agent belonging to the statin class. It is primarily indicated for the management of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production and upregulation of LDL receptors in the liver, enhancing clearance of LDL from the bloodstream. Jubira 40 is prescribed as an adjunct to diet and lifestyle modifications, including exercise and weight control, for patients who require significant lipid reduction to lower the risk of cardiovascular events such as myocardial infarction, stroke, and angina. The 40 mg dosage is typically reserved for patients who have not achieved target lipid levels with lower doses or those at high risk for cardiovascular disease. Caution is advised in patients with hepatic impairment, renal dysfunction, or a history of muscle disorders. Regular monitoring of liver enzymes and creatine kinase is recommended during therapy. Jubira 40 should be used under medical supervision to optimize therapeutic outcomes and minimize adverse effects.